Predicting the Risk of Metastases by PSMA-PET/CT—Evaluation of 335 Men with Treatment-Naïve Prostate Carcinoma

Predicting the Risk of Metastases by PSMA-PET/CT—Evaluation of 335 Men with Treatment-Naïve Prostate Carcinoma

Men diagnosed with aggressive prostate cancer are at high risk of local relapse or systemic progression after definitive treatment. Treatment intensification is highly needed for that patient cohort; however, no relevant stratification tool has been implemented into the clinical work routine so far....

Full description

Bibliographic Details
Main Authors: Stefan A. Koerber, Johannes Boesch, Clemens Kratochwil, Ingmar Schlampp, Jonas Ristau, Erik Winter, Stefanie Zschaebitz, Luisa Hofer, Klaus Herfarth, Klaus Kopka, Tim Holland-Letz, Dirk Jaeger, Markus Hohenfellner, Uwe Haberkorn, Juergen Debus, Frederik L. Giesel
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
prostate cancer
PSMA
PET
metastases
intraprostatic SUV
Online Access:https://www.mdpi.com/2072-6694/13/7/1508

Internet

https://www.mdpi.com/2072-6694/13/7/1508

Similar Items